Considering IL-13 protein levels in T-cell subsets from patients with SSc, the mean percentages of IL-13-producing CD4+ and CD8+ T cells were 3.86 ± 1.4 % and 1.3 ± 0.5 %, respectively. This evidence concerns the gene CD8A and systemic sclerosis.